ARIA Insider Trading Activity and SEC Form 4 Filings
ARIA insider trading summary
No open-market insider purchases or sales of Ariad Pharmaceuticals Inc (ARIA) have been reported on SEC Form 4 in the past 12 months.
Latest ARIA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 9, 2017 | Daniel M Bollag | Sr. VP, Reg. Affairs & Quality | Sell | $761K (32,000 @ $23.78) |
| Oct 24, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $188K (19,638 @ $9.56) |
| Oct 3, 2016 | Daniel M Bollag | Sr. VP, Reg. Affairs & Quality | Sell | $638K (47,384 @ $13.46) |
| Sep 28, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $122K (8,750 @ $13.98) |
| Sep 22, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $269K (20,000 @ $13.43) |
| Sep 15, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $696K (59,369 @ $11.73) |
| Aug 22, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $204K (19,436 @ $10.47) |
| Aug 12, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $263K (25,000 @ $10.50) |
| Jul 22, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $148K (18,286 @ $8.11) |
| Jul 1, 2016 | Timothy P Clackson | President, R&D, CSO | Sell | $235K (31,422 @ $7.48) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.